Dr Andre Choulika | Chairman & Chief Executive Officer
Cellectis

Dr Andre Choulika, Chairman & Chief Executive Officer, Cellectis

André Choulika, Ph.D., is one of the founders of Cellectis and has been Chairman of the Board and Chief Executive Officer since 2000. He has also been President of Calyxt since August 2010. From 1997 to 1999, Dr. Choulika worked as a post-doctoral fellow in the Division of Molecular Medicine at Boston Children’s Hospital, where he was a pioneer in the analysis and use of meganucleases to modify complex genomes. After receiving his Ph.D. in molecular virology from the University of Paris VI (Pierre et Marie Curie), he completed a research fellowship in the Harvard Medical School Department of Genetics. André Choulika also has management training from the HEC (Challenge +).

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 14:30

Panel Discussion: How can clinical challenges be overcome to enable CAR-T and immunotherapy to help more patients?

Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 17:30

Off-The-Shelf CAR-Ts: How do we overcome CAR T immunotherapy limitations

  • Gene-editing is a potent technology for the creation off-the-shelf CAR-Ts
  • Potential ease to re-dose a patient of this novel cell therapeutic strategy
  • Universal CAR-Ts to disrupt the treatment paradigm of cancer

back to speakers

World Advanced Therapies & Regenerative Medicine Congress

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com